DK0409048T3 - Aminoalkylsubstituerede 2-aminothiazoler og terapeutiske midler indeholdende disse - Google Patents

Aminoalkylsubstituerede 2-aminothiazoler og terapeutiske midler indeholdende disse

Info

Publication number
DK0409048T3
DK0409048T3 DK90113143.3T DK90113143T DK0409048T3 DK 0409048 T3 DK0409048 T3 DK 0409048T3 DK 90113143 T DK90113143 T DK 90113143T DK 0409048 T3 DK0409048 T3 DK 0409048T3
Authority
DK
Denmark
Prior art keywords
alkyl
phenyl
aminoalkyl
substituted
thienyl
Prior art date
Application number
DK90113143.3T
Other languages
Danish (da)
English (en)
Inventor
Hans-Juergen Dr Teschendorf
Liliane Dr Unger
Beatrice Dr Rendenbach-Mueller
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of DK0409048T3 publication Critical patent/DK0409048T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK90113143.3T 1989-07-18 1990-07-10 Aminoalkylsubstituerede 2-aminothiazoler og terapeutiske midler indeholdende disse DK0409048T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3923675A DE3923675A1 (de) 1989-07-18 1989-07-18 Amonoalkylsubstituierte 2-aminothiazole und diese enthaltende therapeutische mittel

Publications (1)

Publication Number Publication Date
DK0409048T3 true DK0409048T3 (da) 1995-03-27

Family

ID=6385246

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90113143.3T DK0409048T3 (da) 1989-07-18 1990-07-10 Aminoalkylsubstituerede 2-aminothiazoler og terapeutiske midler indeholdende disse

Country Status (7)

Country Link
US (1) US5071864A (fr)
EP (1) EP0409048B1 (fr)
JP (1) JPH0352877A (fr)
AT (1) ATE116972T1 (fr)
CA (1) CA2020288A1 (fr)
DE (2) DE3923675A1 (fr)
DK (1) DK0409048T3 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
FR2637596B1 (fr) * 1988-10-11 1992-09-04 Irceba Methyl-4 ((aryl-4 piperazinyl-1)-2 ethyl)-5 thiazole et ses derives, leur procede de preparation et les medicaments en contenant
FR2677021B1 (fr) * 1991-05-31 1993-10-01 Upsa Laboratoires Nouveaux derives de thiazole antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
DE4119756A1 (de) * 1991-06-15 1992-12-17 Basf Ag Aminoalkylsubstituierte 5-mercaptothiazole, ihre herstellung und verwendung
FR2714059B1 (fr) * 1993-12-21 1996-03-08 Sanofi Elf Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
DE4425145A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung von Thiazol- und Thiadiazolverbindungen
KR19980703192A (ko) * 1995-03-22 1998-10-15 우에하라아끼라 티아졸 유도체
KR20000048480A (ko) * 1996-09-20 2000-07-25 우에하라 아끼라 2-카르보닐티아졸 유도체 및 그의 용도
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
BRPI0409492A (pt) * 2003-04-18 2006-05-02 Pharmacia & Up John Company Ll terapias de combinação
US20090238761A1 (en) * 2005-01-03 2009-09-24 Universita Degli Studi Di Siena Novel Aryl Piperazine Derivatives With Medical Utility

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3210368A (en) * 1964-09-29 1965-10-05 Ciba Geigy Corp Certain 2-amino-4-aryl-5-n, n-disubstituted amino-lower alkyl-thiazole compounds
US4411900A (en) * 1980-01-03 1983-10-25 Fujisawa Pharmaceutical Co., Ltd. Benzhydrylpiperozinyl thiazole derivatives and pharmaceutical composition comprising the same
US4935424A (en) * 1988-05-27 1990-06-19 Warner-Lambert Company 4 or 5-(substituted piperazinylalkyl)-2-aminothiazoles as antipsychotic agents

Also Published As

Publication number Publication date
DE3923675A1 (de) 1991-01-24
DE59008226D1 (de) 1995-02-23
EP0409048B1 (fr) 1995-01-11
EP0409048A3 (en) 1991-05-15
US5071864A (en) 1991-12-10
CA2020288A1 (fr) 1991-01-19
JPH0352877A (ja) 1991-03-07
ATE116972T1 (de) 1995-01-15
EP0409048A2 (fr) 1991-01-23

Similar Documents

Publication Publication Date Title
DK0469013T3 (da) Hidtil ukendte arylpyridaziner, fremstilling deraf, anvendelse deraf og lægemidler indeholdende disse
DK91690A (da) Anvendelse af adamantan-derivater til fremstilling af terapeutiske praeparater til behandling af ischaemi
ATE97664T1 (de) Isoxazole und isoxazolin-derivate mit antikonvulsiva und pharmazeutische zusammensetzungen, die sie enthalten.
ES8402262A1 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1,omega-difenil-aza-alcano.
ATE116972T1 (de) Aminoalkylsubstituierte 2-aminothiazole und diese enthaltende therapeutische mittel.
AU7927591A (en) Substituted aminoalkylbiphenyl derivatives
ATE88468T1 (de) Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
ES456575A1 (es) Procedimiento de preparacion de derivados del 2,3-dihidro imidazo (2,1-b)tiazol.
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
IE34205B1 (en) Thienodiazepine derivatives
SE7703974L (sv) 1,3,4-tiadiazolylderivat till anvendning som herbicider och sett att framstella foreningarna
DE68913365D1 (de) 4-Amino-3-carboxynaphthyridin-Derivate, ihre Herstellung und pharmazeutische Zusammensetzungen.
DE59102245D1 (de) N-Phenyl-piperidyl-4-amine und diese enthaltende Arzneimittel.
ATE8387T1 (de) Oxindol-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung.
DE69003935D1 (de) Herstellung eines N-substituierten Phenylendiamins.
DK461687D0 (da) Benzhydryloxyethylpiperidinderivater og salte deraf samt deres fremstilling og anvendelse.
DK197689A (da) Pyridazinderivater
HU892146D0 (en) Process for the preparation of heteroaromatic compounds containing five-membered ring with nitrogen atom
ES2080336T3 (es) Derivados de metilpiperazinoazepina, su preparacion y su utilizacion.
NO883986L (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
ATE2429T1 (de) 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DK610586D0 (da) 5-aminoalkyl-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
JPS53105451A (en) Thiourea derivatives, process for their preparation and controlling agents against harmful organisms containing the same
ES2012766B3 (es) Derivados de imino-3 piridazina, procedimiento de obtencion y formas farmaceuticas que las contienen.
SE7412215L (fr)